Phase 1-2, prospective, randomised, double blind, placebo-controlled, dose escalation, parallel-group study to test the efficacy and safety of homatropine methylbromide oral suspension on selected climacteric symptoms and quality of life in menopausal women not receiving hormonal replacement therapy.

Trial Profile

Phase 1-2, prospective, randomised, double blind, placebo-controlled, dose escalation, parallel-group study to test the efficacy and safety of homatropine methylbromide oral suspension on selected climacteric symptoms and quality of life in menopausal women not receiving hormonal replacement therapy.

Planning
Phase of Trial: Phase I/II

Latest Information Update: 01 Sep 2012

At a glance

  • Drugs Homatropine methylbromide (Primary)
  • Indications Hot flashes
  • Focus Adverse reactions
  • Most Recent Events

    • 01 Sep 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top